Education
About Us
Working with TipRanks
Follow Us
Sigilon Therapeutics, Inc. (SGTX)
:SGTX
SGTX Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sigilon Therapeutics News
SGTX FAQ
What was Sigilon Therapeutics, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Sigilon Therapeutics, Inc.’s market cap?
Currently, no data Available
When is Sigilon Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sigilon Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Sigilon Therapeutics, Inc. overvalued?
According to Wall Street analysts Sigilon Therapeutics, Inc.’s price is currently Undervalued.
Does Sigilon Therapeutics, Inc. pay dividends?
Sigilon Therapeutics, Inc. does not currently pay dividends.
What is Sigilon Therapeutics, Inc.’s EPS estimate?
Sigilon Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sigilon Therapeutics, Inc. have?
Currently, no data Available
What happened to Sigilon Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sigilon Therapeutics, Inc.?
Currently, no hedge funds are holding shares in SGTX